glp-1 type 1 diabetes news Good News: Medications in Look Safe and Promising New study confirms GLP-1 medications

They produce weight loss unlike anything we've seen before, and the more we study them, the longer the list of things they seem to hel

If youre following a GLP-1 plan for weight management, starting your day with the right breakfast can set the tone for balanced energy, appetite control, and sustained fullness

GLP-1 is of relevance to ...

Along the obesity pandemic, the prevalence of non-alcoholic fatty liver disease (NAFLD), often regarded as the hepatic manifestation of the metabolic syndrom...

To address this growing global challenge, the World Health Organization (WHO) has developed a guideline on the use of glucagon-like peptide-1 (GLP-1) based therapies, including GLP-1 receptor agonists and GLP-1/GIP dual agonists, for adults living with obesity.Join us at the virtual launch event in a webinar hosted by WHO in collaboration with the Journal of the American Medical Association (JAMA) on 1 December 2025 at 16:00 CET

has officially crossed the $1 trillion market valuation, becoming the first healthcare company in history to reach the milestonea threshold previously dominated almost entirely by technology giants.